We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Portable, Sample to Answer PCR Device Delivers Accurate Results in 30 Minutes at Point of Need

By LabMedica International staff writers
Posted on 07 Sep 2022
Print article
Image: Q-POC platform - Rapid PCR testing at the point of need (Photo courtesy of QuantuMDx)
Image: Q-POC platform - Rapid PCR testing at the point of need (Photo courtesy of QuantuMDx)

When the requirement is for infectious disease testing, every minute counts to inform treatment decisions and slow the risk of transmission. Having rapid multiplex PCR testing at the point of need can make life better for millions of people in hospitals, clinics, airports, care homes, events, workplaces, and a wider variety of other settings. Now, a portable and simple to use rapid multiplex PCR testing system delivers fast, accurate and actionable results in approximately 30 minutes at the point of need.

The Q-POC platform from QuantuMDx Group Ltd. (Tyne and Wear, UK) compresses an entire molecular diagnosis laboratory into a simple-to-use, accessible and portable single device that produces results in approximately 30 minutes. The many innovative features incorporated into the Q-POC platform make it a safe rapid multiplex PCR testing solution for all clinical environments. With the Q-POC supercharged platform, it is no longer necessary to wait hours or days for test results.

The Q-POCT platform has been engineered to limit the need for highly skilled operators and offer a smooth user experience behind each interaction with its intuitive interface. The software is designed with the simplicity and familiarity of smartphone and tablet interfaces. It requires only three minutes hands-on-time to get each test started, using easy to follow, guided workflows on the touch screen. A ready to use solution, with all its simplicity, accuracy and speed, the Q-POCT requires no calibration or preventive maintenance. Each test cassette contains all the necessary reagents to complete a test and can be stored and shipped at room temperature. Users can just load the cassette and press go.

A ton of tech is behind every result, with intelligent multilingual software algorithms integrated into the Q-POCT platform. Clear, simple test results are automatically generated by sophisticated software algorithms, removing any complicated interpretation of the result. The Q-POCT software has been designed with the user in mind and uses intuitive, user centric software design similar to a smartphone allowing clear and easy reporting. The small, portable, battery-operated Q-POCT system marks a huge leap in rapid multiplex PCR testing. Its compact design, as well as its internal lithium-ion battery, supports use in a wide variety of clinical settings, at the Point of Need.

Related Links:
QuantuMDx Group Ltd. 

Gold Member
Dengue Virus Test
LINEAR Dengue-CHIK
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Plasmodium Parasites Test
Plasmodium Genotyping Real Time PCR Kit
New
Preterm Delivery Test
PREMAQUICK

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: The Accelerate WAVE system delivers rapid AST directly from positive blood culture bottles (Photo courtesy of Accelerate Diagnostics)

Rapid Diagnostic System to Deliver Same-Shift Antibiotic Susceptibility Test Results

The World Health Organization estimates that sepsis impacts around 49 million people worldwide each year, resulting in roughly 11 million deaths, with about 1.32 million of these deaths directly linked... Read more

Pathology

view channel
Image: Steps and methodology of skin biopsy processing for dSTORM (Photo courtesy of Front. Mol. Neurosci. (2024); DOI: 10.3389/fnmol.2024.1431549)

Super-Resolution Imaging Detects Parkinson's 20 Years Before First Motor Symptoms Appear

Parkinson's disease is the second most common neurodegenerative disorder globally, affecting approximately 8.5 million people today. This debilitating condition is characterized by the destruction of ... Read more

Industry

view channel
Image: The Scopio X100 and X100HT full-field digital cell morphology solution (Photo courtesy of Beckman Coulter)

Beckman Coulter and Scopio Labs Add World's First Digital Bone Marrow Imaging and Analysis to Long-Term Partnership

Since 2022, Beckman Coulter (Brea, CA, USA) and Scopio Labs (Tel Aviv, Israel) have been working together to accelerate adoption of the next generation of digital cell morphology. Scopio's X100 and X100HT... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.